1-3 of 3
Joseph M Becerra
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety Profile of L-Glutamine in Patients with Sickle Cell Disease: Data from Post-Marketing Surveillance

Bhawna Rastogi, Sunita Rani, Meiko Mayuzumi, Rafael Razon, Rajani Singh, Jason Goodrow, Joseph M Becerra, Charles W Stark, Yutaka Niihara
Journal: Blood
Blood (2021) 138 (Supplement 1): 4184.
https://doi.org/10.1182/blood-2021-154051
Published: 2021
Journal Articles

The Evaluation of Transfusion Data from the Phase 3 Clinical Study of L-Glutamine in Sickle Cell Disease

Hung Lam, Joseph M Becerra, Charles W Stark, Yutaka Niihara, Michael Callaghan
Journal: Blood
Blood (2021) 138 (Supplement 1): 3116.
https://doi.org/10.1182/blood-2021-154477
Published: 2021
Journal Articles

Consistent Benefit of L-Glutamine Observed across Patients with Low, Medium, and High Number of Crises Reported in the Year Prior to Screening -- Analysis from the Phase 3 Study of L-Glutamine in Sickle Cell Anemia

Yutaka Niihara, MD, Charles William Stark, PharmD, Rafael Razon, MD, Lan T Tran, MPH, Joseph M Becerra, PharmD, Eduard H. Panosyan, MD, Joseph Louis Lasky, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1065.
https://doi.org/10.1182/blood-2018-99-119720
Published: 2018